assay · intermediate · partly written
Microsomal stability assay
Liver microsomes, membrane fragments rich in CYP enzymes, are incubated with a compound and the disappearance of the parent is used to estimate intrinsic clearance.
Also called: liver microsome stability, HLM stability
How well does it predict human clearance? more
In a compiled database, human microsome predictions through the well-stirred model had an average fold error of 2.0 and 42.2 percent were within 2-fold (83 drugs); by extraction class the fold error was 1.3, 2.7 and 2.9 for low, intermediate and high. Obach tested 29 drugs and found predictions best when both blood binding and binding to the microsomes were included; basic compounds bound microsomes most (unbound fraction 0.11 to 1.0) and for acidic compounds ignoring binding gave poor predictions. In a blinded multi-company set of 19 drugs, microsome-based prediction with binding corrections was within 2-fold for 75 percent. 123
Reported, not yet replicated
What the vendor page says more
The vendor describes the incubation and readout and names no limitation. A no-NADPH control to separate enzyme loss from chemical instability is standard practice but the vendor page cited for it was not opened. 4
Reported, not yet replicated
Question answered
Readout physical
Remaining parent compound at set times, measured by mass spectrometry; the slope of ln(remaining) against time gives a rate constant k, then half-life and intrinsic clearance in microlitres per minute per mg protein. 4
Reported, not yet replicated
Not measured
Setting
Where in cascade
Sample prep
Compound incubated with microsomes and the cofactor NADPH at 37 C; aliquots stopped in cold acetonitrile at set times. 4
Reported, not yet replicated
Still open here
- Cost per sample and throughput with a basis and date.
- The Obach 1999 within-2-fold counts (not in the abstract).
Not yet written: Conditions, Throughput, Time per run, Cost, Engineerable variants, Use cases, Before after, Capital, Emerging, ML role, Data availability.
Linked from
Sources
- Bowman CM, Benet LZ. In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction. J Pharm Sci (2019). paper; opened 2026-11-17 all records citing this
- Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos (1999). paper; opened 2026-11-17 all records citing this
- Ring BJ, Chien JY, Adkison KK, Jones HM, et al.. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance. J Pharm Sci (2011). paper; opened 2026-11-17 all records citing this
- Microsomal clearance and stability assay (Domainex). Domainex. vendor-page, not peer reviewed; opened 2026-11-17 all records citing this
Where it sits on the map
History of this record (1)
This record has been changed 1 time, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.
- Throughput class
- medium
- Status
- partly written
- Last updated
- 2026-11-17
- Record
- content/assays/microsomal-stability-assay.json